Real-world therapy usage of TTFields in high-grade glioma patients
Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection
Systemic and local therapies before and after diagnosis of leptomeningeal disease in patients with brain metastases – An explorative, single-center retrospective cohort study